Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Larynx, Hypopharyngeal Squamous Cell Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02388932
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma+25 more
Case Comprehensive Cancer Center 3
Early research (Phase 1)Study completedNCT00019110
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Who this might be right for
Anal CancerCervical CancerEsophageal Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT01313390
What this trial is testing

Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University College, London 4
Testing effectiveness (Phase 2)Study completedNCT00055770
What this trial is testing

Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+19 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT03342911
What this trial is testing

Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery

Who this might be right for
Name Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma+19 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 34
Testing effectiveness (Phase 2)Study completedNCT01884259
What this trial is testing

Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN

Who this might be right for
Squamous Cell Carcinoma of the Hypopharynx Stage IIISquamous Cell Carcinoma of the Hypopharynx Stage IVSquamous Cell Carcinoma of the Larynx Stage III+5 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 100
Early research (Phase 1)Active Not RecruitingNCT06761937
What this trial is testing

Thermotherapy for Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerOropharyngeal CarcinomaHypopharyngeal Carcinoma+3 more
Erasmus Medical Center 2
Early research (Phase 1)Study completedNCT00079053
What this trial is testing

Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
NCIC Clinical Trials Group 19
Testing effectiveness (Phase 2)Ended earlyNCT01245985
What this trial is testing

TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors

Who this might be right for
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal Cancer
Heidelberg University 8
Early research (Phase 1)Study completedNCT04870840
What this trial is testing

Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer

Who this might be right for
Locally Advanced Head and Neck Squamous Cell CarcinomaLocally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell Carcinoma+16 more
M.D. Anderson Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT00003888
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 359
Testing effectiveness (Phase 2)Study completedNCT00851877
What this trial is testing

Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Texas Southwestern Medical Center 37
Large-scale testing (Phase 3)Study completedNCT00002555
What this trial is testing

High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 338
Testing effectiveness (Phase 2)Study completedNCT00281840
What this trial is testing

Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06894459
What this trial is testing

A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancers
Beijing Tongren Hospital 180
Early research (Phase 1)Active Not RecruitingNCT02567422
What this trial is testing

Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer

Who this might be right for
Head and Neck Carcinoma of Unknown PrimaryHead and Neck Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7+9 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Looking for participantsNCT06611137
What this trial is testing

SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx

Who this might be right for
Laryngeal CancerHypopharynx Cancer
Sun Yat-sen University 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07552558
What this trial is testing

Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell CarcinomaHPV-Negative Squamous Cell Carcinoma
Washington University School of Medicine 45
Early research (Phase 1)Looking for participantsNCT05172245
What this trial is testing

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Who this might be right for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Carcinoma of Unknown Primary+24 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)UnknownNCT00720070
What this trial is testing

PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer

Who this might be right for
Head and Neck Cancer
Warwick Medical School 560
Next Page
46